Related Experiment Video
Updated: May 26, 2026

08:18
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Multiple lymphatic basin drainage from cutaneous melanoma as a prognostic factor
Antonio Piñero1, Carlos de Torre, Jorge Martínez-Escribano
1Department of General Surgery, Hospital Universitario Virgen de la Arrixaca, El Palmar, 30120 Murcia, Spain. antonio.pinero@carm.es
World Journal of Surgery
|December 30, 2011
Summary
Multiple lymphatic basin drainage (MLBD) and high Breslow thickness are significant prognostic factors for cutaneous melanoma patients. These factors impact disease-free survival, regardless of sentinel lymph node biopsy (SLNB) results.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- The prognostic significance of multiple lymphatic basin drainage (MLBD) in cutaneous melanoma remains debated.
- Understanding MLBD's impact is crucial for accurate melanoma staging and patient management.
Purpose of the Study:
- To investigate the prognostic differences in cutaneous melanoma based on the presence or absence of MLBD.
- To determine if MLBD is an independent prognostic factor for disease-free survival.
Main Methods:
- A prospective cohort analysis of 112 cutaneous melanoma patients undergoing sentinel lymph node biopsy (SLNB).
- MLBD defined as drainage to two or more nodal basins from a single primary lesion.
- Statistical comparison of demographic/clinical data and multivariate analysis of disease-free survival using logistic regression and Cox models.
Main Results:
- MLBD was associated with male gender and primary tumor location on the trunk.
- Both high Breslow thickness and MLBD correlated with worse disease-free survival in patients with positive and negative SLNB.
- Gender and trunk localization were linked to MLBD presence.
Conclusions:
- Breslow thickness is a significant independent prognostic factor for cutaneous melanoma.
- MLBD is also a statistically significant independent prognostic factor for disease-free survival in cutaneous melanoma patients.
- These findings aid in refining prognostic assessments for melanoma.
